RecallWatchUSA

Home / Brands / RLC Labs

RLC Labs Recalls

24 recalls on record · September 23, 2020 to September 23, 2020 · Drugs

September 23, 2020DrugsFDA
RLC Labs Inc. recalls Nature Throid, 1.5 Grain (97.5 mg) Thyroid USP [Liothyronine (T3) 13.5 mcg, Levothyroxine (T4) 57 mcg], packaged in a) 3
Hazard: Subpotent Drug: FDA analysis found product to be subpotent
September 23, 2020DrugsFDA
RLC Labs Inc. recalls Nature Throid, 2 Grain (130 mg) Thyroid USP [Liothyronine (T3) 18 mcg, Levothyroxine (T4) 76 mcg], packaged in a) 30-cou
Hazard: Subpotent Drug: FDA analysis found product to be subpotent
September 23, 2020DrugsFDA
RLC Labs Inc. recalls Nature Throid, 1.25 Grain (81.25 mg) Thyroid USP [Liothyronine (T3) 11.25 mcg, Levothyroxine (T4) 47.5 mcg], 100-count b
Hazard: Subpotent Drug: FDA analysis found product to be subpotent
September 23, 2020DrugsFDA
RLC Labs Inc. recalls Nature Throid, 3/4 Grain (48.75 mg) Thyroid USP [Liothyronine (T3) 6.75 mcg, Levothyroxine (T4) 28.5 mcg], packaged in a
Hazard: Subpotent Drug: FDA analysis found product to be subpotent
September 23, 2020DrugsFDA
RLC Labs Inc. recalls Nature Throid, 1/2 Grain (32.5 mg) Thyroid USP [Liothyronine (T3) 4.5 mcg, Levothyroxine (T4) 19 mcg], packaged in a) 90
Hazard: Subpotent Drug: FDA analysis found product to be subpotent
September 23, 2020DrugsFDA
RLC Labs Inc. recalls WP Thyroid, Westhroid Pure, 1/2 Grain (32.5 mg) Thyroid USP [Liothyronine (T3) 4.5 mcg, Levothyroxine (T4) 19 mcg], pack
Hazard: Subpotent Drug: FDA analysis found product to be subpotent
September 23, 2020DrugsFDA
RLC Labs Inc. recalls WP Thyroid, Westhroid Pure, 2 Grain (130 mg) Thyroid USP packaged in a) 1,000 Tablets, NDC 64727-5950-2 ; b) 30 Tablets,
Hazard: CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
September 23, 2020DrugsFDA
RLC Labs Inc. recalls WP Thyroid, Westhroid Pure, 1.75 Grain (113.75 mg) Thyroid USP, packaged in a) 1,000 Tablets, NDC 64727-6150-2 ; b) 30 T
Hazard: CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
September 23, 2020DrugsFDA
RLC Labs Inc. recalls WP Thyroid, Westhroid Pure, 1.5 Grain (97.5 mg) Thyroid USP packaged in a) 1,000 Tablets, NDC 64727-5850-2 ; b) 30 Table
Hazard: CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
September 23, 2020DrugsFDA
RLC Labs Inc. recalls WP Thyroid, Westhroid Pure, 1.25 Grain (81.25 mg) Thyroid USP packaged in a) 1,000 Tablets, NDC 64727-6050-2 ; b) 30 Tab
Hazard: CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
September 23, 2020DrugsFDA
RLC Labs Inc. recalls WP Thyroid, Westhroid Pure, 1 Grain (65 mg) Thyroid USP, packaged in a) 1,000 Tablets, NDC 64727-5750-2 ; b) 30 Tablets,
Hazard: CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
September 23, 2020DrugsFDA
RLC Labs Inc. recalls WP Thyroid, Westhroid Pure, 3/4 Grain (48.75 mg) Thyroid USP, packaged in a) 1,000 Tablets, NDC 64727-5650-2 ; b) 30 Tab
Hazard: CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
September 23, 2020DrugsFDA
RLC Labs Inc. recalls WP Thyroid, Westhroid Pure, 1/2 Grain (32.5 mg) Thyroid USP packaged in a) 1,000 Tablets, NDC 64727-5550-2 ; b) 30 Table
Hazard: CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
September 23, 2020DrugsFDA
RLC Labs Inc. recalls WP Thyroid, Westhroid Pure, Thyroid USP, [liothyronine (T3) 2.25 mcg and levothyroxine (T4) 9.5 mcg], 1/4 Grain (16.25 m
Hazard: CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
September 23, 2020DrugsFDA
RLC Labs Inc. recalls Nature-Throid, Thyroid USP [liothyronine (T3) 27 mcg and levothyroxine (T4) 114 mcg], 3 Grain (195 mg) Tablets, packaged
Hazard: CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
September 23, 2020DrugsFDA
RLC Labs Inc. recalls Nature-Throid, Thyroid USP [liothyronine (T3) 22.5 mcg and levothyroxine (T4) 95 mcg], 2.5 Grain (162.5 mg) Tablets, pac
Hazard: CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
September 23, 2020DrugsFDA
RLC Labs Inc. recalls Nature-Throid, Thyroid USP [liothyronine (T3) 20.25 mcg and levothyroxine (T4) 85.5 mcg], 2.25 Grain (146.25 mg) Tablets
Hazard: CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
September 23, 2020DrugsFDA
RLC Labs Inc. recalls Nature-Throid, Thyroid USP [liothyronine (T3) 18 mcg and levothyroxine (T4) 76 mcg], 2 Grain (130 mg) Tablets, packaged
Hazard: CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
September 23, 2020DrugsFDA
RLC Labs Inc. recalls Nature-Throid, Thyroid USP [liothyronine (T3) 15.75 mcg and levothyroxine (T4) 66.5 mcg], 1.75 Grain (113.75 mg) Tablets
Hazard: CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
September 23, 2020DrugsFDA
RLC Labs Inc. recalls Nature-Throid, Thyroid USP [liothyronine (T3) 13.5 mcg and levothyroxine (T4) 57 mcg], 1.5 Grain (97.5 mg) Tablets, pack
Hazard: CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
September 23, 2020DrugsFDA
RLC Labs Inc. recalls Nature-Throid, Thyroid USP [liothyronine (T3) 11.25 mcg and levothyroxine (T4) 47.5 mcg], 1.25 Grain (81.25 mg) Tablets
Hazard: CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
September 23, 2020DrugsFDA
RLC Labs Inc. recalls Nature-Throid, Thyroid USP [liothyronine (T3) 4.5 mcg and levothyroxine (T4) 19 mcg], 1/2 Grain (32.5 mg) Tablets, packa
Hazard: CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
September 23, 2020DrugsFDA
RLC Labs Inc. recalls Nature-Throid, Thyroid USP [liothyronine (T3) 6.75 mcg and levothyroxine (T4) 28.5 mcg], 3/4 Grain (48.75 mg) Tablets, p
Hazard: CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
September 23, 2020DrugsFDA
RLC Labs Inc. recalls Nature-Throid, Thyroid USP [liothyronine (T3) 9 mcg and levothyroxine (T4) 38 mcg], 1 Grain (65 mg) Tablets, packaged in
Hazard: CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
RLC Labs Recalls | RecallWatchUSA